Gene Expression During Acute and Prolonged Hypoxia is Regulated by Distinct Mechanisms of Translational Control

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2006 Feb 10

PMID 16467844

Citations 159

Authors

Marianne Koritzinsky

Michael G Magagnin

Twan van den Beucken

Renaud Seigneuric

Kim Savelkouls

Josee Dostie

Stephane Pyronnet

Randal J Kaufman

Sherry A Weppler

Jan Willem Voncken

Philippe Lambin

Constantinos Koumenis

Nahum Sonenberg

Bradly G Wouters

Affiliations

Soon will be listed here.

Abstract

Hypoxia has recently been shown to activate the endoplasmic reticulum kinase PERK, leading to phosphorylation of eIF2alpha and inhibition of mRNA translation initiation. Using a quantitative assay, we show that this inhibition exhibits a biphasic response mediated through two distinct pathways. The first occurs rapidly, reaching a maximum at 1-2 h and is due to phosphorylation of eIF2alpha. Continued hypoxic exposure activates a second, eIF2alpha-independent pathway that maintains repression of translation. This phase is characterized by disruption of eIF4F and sequestration of eIF4E by its inhibitor 4E-BP1 and transporter 4E-T. Quantitative RT-PCR analysis of polysomal RNA indicates that the translation efficiency of individual genes varies widely during hypoxia. Furthermore, the translation efficiency of individual genes is dynamic, changing dramatically during hypoxic exposure due to the initial phosphorylation and subsequent dephosphorylation of eIF2alpha. Together, our data indicate that acute and prolonged hypoxia regulates mRNA translation through distinct mechanisms, each with important contributions to hypoxic gene expression.

Citing Articles

Cardiomyocytes in Hypoxia: Cellular Responses and Implications for Cell-Based Cardiac Regenerative Therapies.

Dwyer K, Snyder C, Coulombe K Bioengineering (Basel). 2025; 12(2).

PMID: 40001674 PMC: 11851968. DOI: 10.3390/bioengineering12020154.

Adaptation of Natural Killer Cells to Hypoxia: A Review of the Transcriptional, Translational, and Metabolic Processes.

Chang T, Chen Y, Luo J, Zhang C, Chen S, Lin Z Immunotargets Ther. 2025; 14:99-121.

PMID: 39990274 PMC: 11846490. DOI: 10.2147/ITT.S492334.

Tumour hypoxia in driving genomic instability and tumour evolution.

Suvac A, Ashton J, Bristow R Nat Rev Cancer. 2025; 25(3):167-188.

PMID: 39875616 DOI: 10.1038/s41568-024-00781-9.

Glucose deprivation impairs hypoxia-inducible factor-1α synthesis.

Hubert M, Stuart S, Ohh M Discov Oncol. 2024; 15(1):595.

PMID: 39466364 PMC: 11519269. DOI: 10.1007/s12672-024-01484-1.

Ribosome biogenesis and ribosomal proteins in cancer stem cells: a new therapeutic prospect.

Samanta P, Ghosh R, Pakhira S, Mondal M, Biswas S, Sarkar R Mol Biol Rep. 2024; 51(1):1016.

PMID: 39325314 DOI: 10.1007/s11033-024-09963-y.

References

Holland E, Sonenberg N, Pandolfi P, Thomas G . Signaling control of mRNA translation in cancer pathogenesis. Oncogene. 2004; 23(18):3138-44. DOI: 10.1038/sj.onc.1207590. View

Andrei M, Ingelfinger D, Heintzmann R, Achsel T, Rivera-Pomar R, Luhrmann R . A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA. 2005; 11(5):717-27. PMC: 1370757. DOI: 10.1261/rna.2340405. View

Blais J, Filipenko V, Bi M, Harding H, Ron D, Koumenis C . Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol Cell Biol. 2004; 24(17):7469-82. PMC: 506979. DOI: 10.1128/MCB.24.17.7469-7482.2004. View

Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee A, Yoshida H . XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 2004; 64(17):5943-7. DOI: 10.1158/0008-5472.CAN-04-1606. View

Cardenas-Navia L, Yu D, Braun R, Brizel D, Secomb T, Dewhirst M . Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing. Cancer Res. 2004; 64(17):6010-7. DOI: 10.1158/0008-5472.CAN-03-0947. View

Robertson N, Potter C, Harris A . Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res. 2004; 64(17):6160-5. DOI: 10.1158/0008-5472.CAN-03-2224. View

Bennewith K, Durand R . Quantifying transient hypoxia in human tumor xenografts by flow cytometry. Cancer Res. 2004; 64(17):6183-9. DOI: 10.1158/0008-5472.CAN-04-0289. View

Gebauer F, Hentze M . Molecular mechanisms of translational control. Nat Rev Mol Cell Biol. 2004; 5(10):827-35. PMC: 7097087. DOI: 10.1038/nrm1488. View

Lu P, Harding H, Ron D . Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J Cell Biol. 2004; 167(1):27-33. PMC: 2172506. DOI: 10.1083/jcb.200408003. View

10.

Lawson T, Cladaras M, Ray B, Lee K, Abramson R, Merrick W . Discriminatory interaction of purified eukaryotic initiation factors 4F plus 4A with the 5' ends of reovirus messenger RNAs. J Biol Chem. 1988; 263(15):7266-76. View

11.

Lejbkowicz F, Goyer C, Darveau A, Neron S, Lemieux R, Sonenberg N . A fraction of the mRNA 5' cap-binding protein, eukaryotic initiation factor 4E, localizes to the nucleus. Proc Natl Acad Sci U S A. 1992; 89(20):9612-6. PMC: 50182. DOI: 10.1073/pnas.89.20.9612. View

12.

Lefebvre V, van Steenbrugge M, Beckers V, Roberfroid M . Adenine nucleotides and inhibition of protein synthesis in isolated hepatocytes incubated under different pO2 levels. Arch Biochem Biophys. 1993; 304(2):322-31. DOI: 10.1006/abbi.1993.1357. View

13.

Pause A, Belsham G, Gingras A, Donze O, Lin T, Lawrence Jr J . Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature. 1994; 371(6500):762-7. DOI: 10.1038/371762a0. View

14.

Graeber T, Osmanian C, Jacks T, Housman D, Koch C, Lowe S . Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 1996; 379(6560):88-91. DOI: 10.1038/379088a0. View

15.

Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E . Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol. 1998; 18(6):3112-9. PMC: 108893. DOI: 10.1128/MCB.18.6.3112. View

16.

RYAN H, Lo J, Johnson R . HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998; 17(11):3005-15. PMC: 1170640. DOI: 10.1093/emboj/17.11.3005. View

17.

Johannes G, Carter M, Eisen M, Brown P, Sarnow P . Identification of eukaryotic mRNAs that are translated at reduced cap binding complex eIF4F concentrations using a cDNA microarray. Proc Natl Acad Sci U S A. 1999; 96(23):13118-23. PMC: 23910. DOI: 10.1073/pnas.96.23.13118. View

18.

Dostie J, Ferraiuolo M, Pause A, Adam S, Sonenberg N . A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5' cap-binding protein, eIF4E. EMBO J. 2000; 19(12):3142-56. PMC: 203362. DOI: 10.1093/emboj/19.12.3142. View

19.

Martin M, Munoz F, Salinas M, Fando J . Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem J. 2000; 351 Pt 2:327-34. PMC: 1221367. View

20.

Jaakkola P, Mole D, Tian Y, Wilson M, Gielbert J, Gaskell S . Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292(5516):468-72. DOI: 10.1126/science.1059796. View